Prameha(Diabetes) treatment by Haridradigana Basti and Haridradigana ghana Vati

Comparative evaluation of efficacy of Haridradigana Yoga Basti with Haridradigana ghana Vati and Metformin in the management of Diabetes Mellitus Type II (Prameha)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038908

Enrollment

Registered

2021-12-24

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with either sex having age between 20 -60 years 2.Patients recently diagnosed for uncomplicated NIDDM (type 2 diabetes) and having Fasting blood sugar level >=126 mg/dl Post meal blood sugar level >=140 mg/dl 3.HbA1c >= 6.57 4.Old cases of type-2 DM not taking any other anti-hypoglycaemic drugs. 5.Diabetic Patients suffering from Controlled Hypertension (Blood Pressure not more than >=140 mmHg or an average Diastolic Blood Pressure not more than >=90 mmHg) 6.Patients willing to give informed consent 7.Patient fit for Basti Karma as per the Ayurvedic classics

Exclusion criteria

Exclusion criteria: 1.Patients suffering from IDDM (Insulin dependent diabetes mellitus) & patient with Type -2 Diabetes on insulin therapy 2.Patients suffering from Juvenile Diabetes or Gestational diabetes (ICD â?? 10 criteria 024) 3.DM with complications e.g. Retinopathy, Nephropathy, neuropathy ,previous history of coma 4.Patients suffering from any current acute illness, uncontrolled hypertension

Design outcomes

Primary

Measure	Time frame
Relief in clinical features associated with Diabetes Mellitus Type II(Prameha)Timepoint: 1/2 month(45 days)	—

Secondary

Measure	Time frame
1 To assess the efficacy of Haridradigana Yoga Basti with Haridradigana Ghana Vati over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II 2 To assess the efficacy of Metformin over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II 3 To compare the efficacy of Haridradigana Yoga Basti with Haridradigana Ghana Vati and Metformin over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II Timepoint: 1/2 month(45 days)	—

Measure

Time frame

1 To assess the efficacy of Haridradigana Yoga Basti with Haridradigana Ghana Vati over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II 2 To assess the efficacy of Metformin over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II 3 To compare the efficacy of Haridradigana Yoga Basti with Haridradigana Ghana Vati and Metformin over objective parameters ie Blood sugar levels (Fasting and Post Prandial) Urine Sugar level HbA1c in Diabetes Mellitus Type II Timepoint: 1/2 month(45 days)

—

Countries

India

Contacts

Public ContactDr Punam Sawarkar

Mahatma Gandhi Ayurveda College Hospital and Research Centre Salod(H),Wardha

drsuple.punam@gmail.com9860667023

Outcome results